Registration for a live webinar on 'Innovative Vaccines and Viral Pathogenesis: Insights from Recent Monkeypox Research' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
- Research interviews
-
1. The regulation of cell therapy
- Prof. Moutih Rafei
-
2. How and why neurons die in Alzheimer's disease?
- Prof. Bart De Strooper
-
3. The future of blood tests in cancer treatment
- Dr. Isaac Garcia-Murillas
-
4. Role of marketing authorization holder in drug safety
- Dr. Raphael Elmadjian Pareschi
-
5. Synthetic whole embryo models and their applications
- Prof. Jacob (Yaqub) Hanna
-
6. Scale-up challenges in the production of nanomedicines from lab to industry
- Prof. Dr. Oya Tagit
-
7. Artificial intelligence in precision medicine
- Dr. Michael P. Menden
-
8. Translational medicine: the risk of failure in delay and how to reduce it
- Prof. Martin Wehling
-
9. Challenges and solutions of scaling up
- Dr. Shaukat Ali
-
11. Management of generic drug development: challenges and opportunities
- Mr. Sandeep Patil
-
12. MassBank development and future
- Dr. Emma L. Schymanski
-
13. Elite controllers of HIV: from discovery to future therapies
- Prof. Bruce Walker
-
14. Translational research in amyotrophic lateral sclerosis (ALS)
- Prof. Aaron D. Gitler
-
16. PANDAS: a potential link between group A streptococcal infections and neurological disorders
- Prof. P. Patrick Cleary
-
17. Rheumatic diseases and musculoskeletal pain
- Prof. Anisur Rahman
-
18. Towards developing a universal influenza vaccine
- Prof. Peter Palese
- Clinical interviews
-
19. Monkeypox: etiopathogenesis, prevention, and treatments
- Dr. Dennis Hruby
-
20. Kidney xenotransplantation
- Dr. Douglas J. Anderson
-
21. CAR-T and TCR-T cellular immunotherapies in oncology
- Prof. Sebastian Kobold
-
22. MAPS: the business of medical affairs
- Dr. Danie du Plessis
-
23. Hypertrophic cardiomyopathy: therapies and treatments
- Prof. Srihari Naidu
-
24. Combating the HIV epidemic
- Prof. William Blattner
-
25. Epigenetic pharmaceuticals used in the clinic
- Dr. Thomas Paul
-
26. Precision cancer medicine: development and future
- Prof. Maurie Markman
-
27. Pediatric cancer testing
- Prof. Joshua Schiffman
-
28. Opposition to vaccination: a transatlantic discussion
- Prof. Jonathan Temte
-
29. Elective caesarean sections from an evolutionary perspective
- Prof. Wenda Trevathan
-
30. Antiphospholipid syndrome and Lupus
- Prof. Graham Hughes
-
31. Prescribing medications to children - a GP’s view
- Dr. Amanda Simmons
Topics Covered
- The discovery of HIV and elite controllers
- Initial research and clinical trials
- From HIV elite controllers to an HIV vaccine
- HIV structural constraints, structurally important regions and viral fitness
- Current and future challenges in HIV treatments
Biography
Bruce D. Walker, M.D. is the Phillip T. and Susan M. Ragon Professor of Immunology and Medicine at Harvard Medical School, Professor of Microbiology and Immunobiology at Harvard T.H. Chan School of Public Health, and a Howard Hughes Medical Institute (HHMI) Investigator. He is the founding and current director of the Ragon Institute of MGH, MIT and Harvard, whose mission is to create cross-disciplinary collaborations in order to harness the immune system to prevent and cure human disease. In addition to his clinical duties as an Infectious Disease specialist at Massachusetts General Hospital, his research focuses on cellular immune responses in chronic human viral infections, with a particular focus on HIV immunology and vaccine development. He leads an international translational clinical and basic science research effort to understand how some rare people who are infected with HIV, but have never been treated, can fight the virus with their immune system.
Dr. Walker is also an Adjunct Professor at the Nelson Mandela School of Medicine in Durban, South Africa. He is a co-founder of the KwaZulu-Natal Research Institute for TB and HIV (K-RITH, recently renamed the Africa Health Research Institute, AHRI), an initiative initially funded by HHMI to build a state-of-the-art TB/HIV research facility at the heart of these dual epidemics in South Africa.
Dr. Walker is also a member of the American Academy of Arts and Sciences, American Society for Clinical Investigation (ASCI), the American Association of Physicians (AAP), and the National Academy of Medicine. He received his M.D. from Case Western Reserve University and his B.A. in Chemistry from the University of Colorado, and has been on the Harvard faculty since 1980.
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Walker, B. (2020, April 14). Elite controllers of HIV: from discovery to future therapies [Audio file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 9, 2024, from https://doi.org/10.69645/MXJT2430.Export Citation (RIS)
Publication History
Financial Disclosures
- There are no commercial/financial matters to disclose